Cargando…
Trends in the crossover of patients in phase III oncology clinical trials in the USA
BACKGROUND: The incorporation of crossover in randomised controlled trials is accepted as an ethical obligation, especially in cancer clinical trials. The more common type of crossover is crossover allowance, which allows patients assigned to one arm to switch to another arm if there is an establish...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cancer Intelligence
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7738270/ https://www.ncbi.nlm.nih.gov/pubmed/33343701 http://dx.doi.org/10.3332/ecancer.2020.1142 |